Pathos Communications — Evidence that H2 acceleration is materialising

Pathos Communications (AIM: NEWS)

Last close As at 08/09/2026

GBP0.26

0.00 (0.00%)

Market capitalisation

GBP18m

More on this equity

Research: TMT

Pathos Communications — Evidence that H2 acceleration is materialising

Pathos’s H126 results confirm encouraging H1 performance, with robust trading through July and August indicating that the acceleration anticipated for H2 is now materialising. Good progress across key KPIs, including repeat business rising to 36% of revenue from 16% in H125 and gross margin improving sequentially to 71% from 69% in H225, further supports the expectation that growth can translate into increasing operational leverage. Pathos continues to trade on value-like multiples that appear to give limited credit to its large addressable market, proprietary technology, scalability potential and encouraging execution since IPO.

Written by

Dan Ridsdale

Head of Technology

Media

QuickView

9 September 2026

Price 26.00p
Market cap £17m
Price Performance
Share details
Code NEWS
Listing AIM

Shares in issue

66.7m

Net cash/(debt) at June 2026

$5.9m

Business description

Pathos Communications is a technology-enabled, human-led public relations company that leverages AI to democratise SMEs’ access to established news publications using a pay-on-results model. The company combines proprietary AI tools, such as PathosMind and Pressella, with expert editorial teams to deliver scalable media coverage for over 7,000 clients across 90 countries.

Bull points

  • A differentiated model addressing a large addressable market.
  • Execution since IPO has been encouraging, with H126 revenue up 14% to $7.3m and management confident of meeting FY26 market expectations.
  • Early signs of operational leverage are evident, and a rising repeat-revenue mix reducing the cost of incremental sales.

Bear points

  • Execution risk as the model remains relatively untested as a listed business, with a limited public track record and key milestones still to deliver.
  • The pay-on-results structure leaves revenue exposed to conversion and collection risk.
  • SME market is highly fragmented, making efficient customer acquisition and retention critical to scaling.

Analysts

Dan Ridsdale
+44 (0)20 3077 5700
Chloe Wong
+44 (0)20 3077 5700

Pathos Communications is a research client of Edison Investment Research Limited

The headline H1 figures were largely pre-announced in July, with revenue up 14% to $7.3m and adjusted EBITDA up 36% to $1.73m, lifting the margin to 23.7% from 19.8%. Customer receipts increased to $7.9m from $4.3m, while bad-debt expense fell sharply to $0.28m from $1.55m following improvements to credit control and collection processes. Additionally, accruals and deferred income totalling c $1m provides further support for H2. Operating cash generation of $1.74m was effectively in line with adjusted EBITDA, while the group invested $1.72m in intangible assets, including its technology platform and customer databases.

Key KPIs continue to move in the right direction. Repeat customers represented 36% of H1 revenue versus 16% in H125, while the annualised run rate of new contracts signed in the repeat business is tracking at over 75% of the current FY27 revenue market expectation. Gross margin improved sequentially to 71% from 69% in H225. Both metrics provide support for the company’s potential to sustain operationally leveraged growth. Pathos is also broadening its offer through podcast services, book publishing and access to prime business TV slots, alongside a new 24-month agreement with a ‘Big Three’ US news periodical. The planned H127 general availability of PathosMind and Pressella should provide a further catalyst for growth and efficiency. Management is also evaluating acquisitions that could expand the customer base and provide further scope to deploy Pathos’s technology and operating model.

Management expects FY26 performance to meet or slightly exceed market expectations, and we note that consensus FY26 revenue and FY27 revenue and EBITDA estimates have been nudged up. Pathos nevertheless continues to trade on value-like multiples, including a single-digit FY27 P/E. These multiples appear to assign limited credit to the addressable market, proprietary technology, scalability potential or the company’s encouraging execution since IPO. Continued evidence of H2 acceleration, improving revenue quality and operational leverage should support the case for a meaningful re-rating.

See our recent interview with Pathos founder and CEO Omar Hamdi here.

Source: Pathos, LSEG Data & Analytics. Note: EBIT, EBITDA, PBT are adjusted, EPS is adjusted and fully diluted.

Consensus estimates

Year end Revenue ($m) EBIT ($m) EBITDA ($m) PBT ($m) EPS (¢) P/E (x) EV/EBITDA (x)
12/25 13.1 2.2 2.9 2.0 2.58 13.6 6.1
12/26e 15.0 2.8 4.0 2.7 3.60 9.8 4.4
12/27e 16.5 3.3 5.0 3.2 4.30 8.2 3.5

General disclaimer and copyright

This report has been commissioned by Pathos Communications and prepared and issued by Edison, in consideration of a fee payable by Pathos Communications. Edison Investment Research standard fees are £60,000 pa for the production and broad dissemination of a detailed note (Outlook) following by regular (typically quarterly) update notes. Fees are paid upfront in cash without recourse. Edison may seek additional fees for the provision of roadshows and related IR services for the client but does not get remunerated for any investment banking services. We never take payment in stock, options or warrants for any of our services.

Accuracy of content: All information used in the publication of this report has been compiled from publicly available sources that are believed to be reliable, however we do not guarantee the accuracy or completeness of this report and have not sought for this information to be independently verified. Opinions contained in this report represent those of the research department of Edison at the time of publication. Forward-looking information or statements in this report contain information that is based on assumptions, forecasts of future results, estimates of amounts not yet determinable, and therefore involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of their subject matter to be materially different from current expectations.

Exclusion of Liability: To the fullest extent allowed by law, Edison shall not be liable for any direct, indirect or consequential losses, loss of profits, damages, costs or expenses incurred or suffered by you arising out or in connection with the access to, use of or reliance on any information contained on this note.

No personalised advice: The information that we provide should not be construed in any manner whatsoever as, personalised advice. Also, the information provided by us should not be construed by any subscriber or prospective subscriber as Edison’s solicitation to effect, or attempt to effect, any transaction in a security. The securities described in the report may not be eligible for sale in all jurisdictions or to certain categories of investors.

Investment in securities mentioned: Edison has a restrictive policy relating to personal dealing and conflicts of interest. Edison Group does not conduct any investment business and, accordingly, does not itself hold any positions in the securities mentioned in this report. However, the respective directors, officers, employees and contractors of Edison may have a position in any or related securities mentioned in this report, subject to Edison's policies on personal dealing and conflicts of interest.

Copyright 2026 Edison Investment Research Limited (Edison).

Australia

Edison Investment Research Pty Ltd (Edison AU) is the Australian subsidiary of Edison. Edison AU is a Corporate Authorised Representative (1252501) of Crown Wealth Group Pty Ltd who holds an Australian Financial Services Licence (Number: 494274). This research is issued in Australia by Edison AU and any access to it, is intended only for "wholesale clients" within the meaning of the Corporations Act 2001 of Australia. Any advice given by Edison AU is general advice only and does not take into account your personal circumstances, needs or objectives. You should, before acting on this advice, consider the appropriateness of the advice, having regard to your objectives, financial situation and needs. If our advice relates to the acquisition, or possible acquisition, of a particular financial product you should read any relevant Product Disclosure Statement or like instrument.

New Zealand

The research in this document is intended for New Zealand resident professional financial advisers or brokers (for use in their roles as financial advisers or brokers) and habitual investors who are “wholesale clients” for the purpose of the Financial Advisers Act 2008 (FAA) (as described in sections 5(c) (1)(a), (b) and (c) of the FAA). This is not a solicitation or inducement to buy, sell, subscribe, or underwrite any securities mentioned or in the topic of this document. For the purpose of the FAA, the content of this report is of a general nature, is intended as a source of general information only and is not intended to constitute a recommendation or opinion in relation to acquiring or disposing (including refraining from acquiring or disposing) of securities. The distribution of this document is not a “personalised service” and, to the extent that it contains any financial advice, is intended only as a “class service” provided by Edison within the meaning of the FAA (i.e. without taking into account the particular financial situation or goals of any person). As such, it should not be relied upon in making an investment decision.

United Kingdom

This document is prepared and provided by Edison for information purposes only and should not be construed as an offer or sol icitation for investment in any securities mentioned or in the topic of this document. A marketing communication under FCA Rules, this document has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and is not subject to any prohibition on dealing ahead of the dissemination of investment research.

This Communication is being distributed in the United Kingdom and is directed only at (i) persons having professional experience in matters relating to investments, i.e. investment professionals within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "FPO") (ii) high net-worth companies, unincorporated associations or other bodies within the meaning of Article 49 of the FPO and (iii) persons to whom it is otherwise lawful to distribute it. The investment or investment activity to which this document relates is available only to such persons. It is not intended that this document be distributed or passed on, directly or indirectly, to any other class of persons and in any event and under no circumstances should persons of any other description rely on or act upon the contents of this document.

This Communication is being supplied to you solely for your information and may not be reproduced by, further distributed to or published in whole or in part by, any other person.

United States

Edison relies upon the "publishers' exclusion" from the definition of investment adviser under Section 202(a)(11) of the Investment Advisers Act of 1940 and corresponding state securities laws. This report is a bona fide publication of general and regular circulation offering impersonal investment-related advice, not tailored to a specific investment portfolio or the needs of current and/or prospective subscribers. As such, Edison does not offer or provide personal advice and the research provided is for informational purposes only. No mention of a particular security in this report constitutes a recommendation to buy, sell or hold that or any security, or that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific person.

London │ New York │ Frankfurt

20 Red Lion Street

London, WC1R 4PS

United Kingdom

More on Pathos Communications

View All

Latest from the TMT sector

View All TMT content

Research: Healthcare

Newron Pharmaceuticals — Strengthened funding ahead of pivotal readout

Newron has received a further €5.5m as the second tranche under the (up to) €38m equity financing agreed with an investor group in February 2026, through the issue of 433,070 new shares. This follows the initial €15m investment, with a third €5.5m tranche expected by end-November 2026, as the pivotal ENIGMA-TRS programme progresses; a final €12m remains conditional on positive study results. The latest funding provides additional operational headroom as Newron advances evenamide through Phase III development in treatment-resistant schizophrenia (TRS). With ENIGMA-TRS 1 screening now complete, we believe investor attention has turned towards the first 12-week top-line results from the international ENIGMA-TRS 1 study, anticipated in Q127, which we view as a key potential near-term catalyst.

Continue Reading
Cookie Policy Overview
Edison Group

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping us understand which section of the website you find more interesting and useful. See our Cookie Policy for more information.

Strictly necessary and functional

These cookies are used to deliver our website and content. Strictly necessary cookies relate to our hosting environment, and functional cookies are used to facilitate social logins, social sharing and rich-media content embeds.

Advertising

Advertising Cookies collect information about your browsing habits such as the pages you visit and links you follow. These audience insights are used to make our website more relevant.

Performance

Performance Cookies collect anonymous information designed to help us improve the site and respond to the needs of our audiences. We use this information to make our site faster, more relevant and improve the navigation for all users.